Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Servidei

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Journal of Neurology|July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfaT Mongini, G Gadaleta, P Alonge, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2015
LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk populationO Musumeci, G la Marca, M Spada, et al.
Journal of Neurology|August 18, 2022
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohortV Montano, P Lopriore, F Gruosso, et al.
Neurology|July 23, 1998
Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patientsE Pegoraro, H Marks, C A Garcia, et al.
Journal of Neurology|July 12, 2017
Revisiting mitochondrial ocular myopathies: a study from the Italian NetworkD Orsucci, C Angelini, E Bertini, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Journal of Neurology|July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfaT Mongini, G Gadaleta, P Alonge, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 19, 2015
LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk populationO Musumeci, G la Marca, M Spada, et al.
Journal of Neurology|August 18, 2022
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohortV Montano, P Lopriore, F Gruosso, et al.
Neurology|July 23, 1998
Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patientsE Pegoraro, H Marks, C A Garcia, et al.
Journal of Neurology|July 12, 2017
Revisiting mitochondrial ocular myopathies: a study from the Italian NetworkD Orsucci, C Angelini, E Bertini, et al.
Pageof 15